Saad kenderian
@kenderian_ss
Hematology, Bone Marrow Transplantation, Immunotherapy, CART cell therapy, Mayo Clinic, Rochester, MN
ID: 4498029973
08-12-2015 15:25:15
554 Tweet
1,1K Followers
311 Following
.Mayo Clinic Comprehensive Cancer Center director @cherylwillmanmd is part of @NCICRCHD’s newly established team of Cancer Equity Leaders. This diverse group of cancer leaders will reimagine and transform the future of cancer #HealthEquity. Learn more: bit.ly/49zzAMv
The NPPA Exec team is thrilled to announce the launch of the Mayo Clinic Office of NP PAs - Rochester! 🎉 A culmination of years of hard work & a testimony to Mayo Clinic Rochester’s commitment to recognizing contributions of NPs & PAs across patient care, education, & research!
Congratulations Paul Hampel on receiving the best abstract award at the 2024 YIM GCLLSG meeting in Koln! A fantastic conference! #GCLLSG Mayo Clinic Comprehensive Cancer Center Michael Hallek Deborah Stephens
What is the role of AI-ECG in #CardioOnc? Check out this Mayo Clinic #AF risk score study in CLL by Sameer Parikh Zachi Attia Wei Ding Saad kenderian Yucai Wang, MD, PhD Paul Hampel Amber Koehler, PA-C Prashant Kapoor Peter Noseworthy, MD Paul Friedman, MD Joerg Herrmann #JACCCardioOnc tinyurl.com/ekxw49ny
Unlocking Hope: From #GeneEditing to #ImmuneRevolution 🧪🫀🩺🩸Exploring the frontiers of #GeneEditing and #Immunotherapy at the #AnnualGenomicsForum2024 with today's first panel Saad kenderian, Megan Levings, Nathan Michaels, Kevin Song and @kylahingwing! 🔬🧬 #GenomicsForum2024
Thank you to @kylahingwing for a successful first panel at the #AnnualGenomicsForum2024 with Saad kenderian, Megan Levings, Nathan Michaels and Kevin Song! #GenomicsForum2024
A comprehensive review of how TME interacts with #cart and cancer cells and strategies to overcome inhibition Lionel Fonkoua, MD Olivia Sirpilla R. Leo Sakemura Mayo Clinic Mayo Clinic Comprehensive Cancer Center
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities Cell Press Cell Molecular Therapy Lionel Fonkoua, MD Saad kenderian Sara Elizabeth Siegler Olivia Sirpilla #CARTcells doi.org/10.1016/j.omto…
Read the new InFocus article by @Carlhjune and Marco Ruella— CAR T cell resistance to oncogenic transformation. bit.ly/3V0sRXR Penn Medicine
Dr. Saad kenderian explains the ongoing research taking place to potentially move #CARTCellTherapy into earlier lines of therapy for patients with chronic lymphocytic #leukemia. Via OncLive.com: bit.ly/3wNG6So
Drs. Saad kenderian and John Copland are collaborating across Mayo Clinic Comprehensive Cancer Center sites as principal investigators researching #CARTCellTherapy for solid #ThyroidCancer tumors. To drive this promising therapy closer to patients, they're addressing four hurdles: mayocl.in/3ySpGIQ
Mayo Clinic Allison Garda Shaji Kumar Judy Boughey 1–1:30 p.m.: Meet hematologist/oncologist and lymphoproliferative diseases expert Dr. Paul Hampel at Booth No. 27104. Paul Hampel #ASCO24
The answer is NO. Here's a patient with neuroblastoma who was treated 18 years ago with GD2.CAR T cells at Baylor Center for Cell and Gene Therapy and still remains in remission. We need more of these stories. researchsquare.com/article/rs-423…
Saad kenderian Mayo Clinic U.S. FDA 💡If you want to learn more on CAR-MSC please read CAR-MSC article on Nature Biomedical Engineering by Olivia Sirpilla in Saad kenderian's lab at Mayo Clinic Rochester: 📚pubmed.ncbi.nlm.nih.gov/38561490/ 🔗isctglobal.org/telegrafthub/b…
Look forward to moving this technology to the clinic Mayo Clinic MayoRegMed Mayo Clinic Comprehensive Cancer Center Olivia Sirpilla
Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models. Penn Medicine Ruella Lab science.org/doi/10.1126/sc…